找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Prevention II; Hans-Jörg Senn,Ursula Kapp,Florian Otto Conference proceedings 2009 Springer-Verlag Berlin Heidelberg 2009 ER-negati

[复制链接]
查看: 18649|回复: 63
发表于 2025-3-21 19:31:49 | 显示全部楼层 |阅读模式
书目名称Cancer Prevention II
编辑Hans-Jörg Senn,Ursula Kapp,Florian Otto
视频video
概述Includes supplementary material:
丛书名称Recent Results in Cancer Research
图书封面Titlebook: Cancer Prevention II;  Hans-Jörg Senn,Ursula Kapp,Florian Otto Conference proceedings 2009 Springer-Verlag Berlin Heidelberg 2009 ER-negati
描述More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on “Primary Therapy of Early Breast Cancer” as well as “Supportive Care in Cancer” for more than 20 years, the idea of promoting interdisciplinary, clinically oriented meetings on cancer prevention is a more recent and not yet generally accepted and w- comed concept in modern oncology. Since today’s medical expenses are soaring and me- cal research budgets are stagnating or even being cut, neither politicians nor industry is willing to risk an additional unpredictable channel of expenses, such as that demanded by clinical cancer prevention efforts! In Switzerland—and we fear in many other parts of the globe—some 97%–98% or even a greater percentage of health budgets is spent for curative and palliative/rehabilitative m- icine. Since a meager 2%–3% of national health budgets is for preventive medicine,
出版日期Conference proceedings 2009
关键词ER-negative breast cancer; Prevention of breast cancer; Primary prevention; cancer prevention; chemoprev
版次1
doihttps://doi.org/10.1007/978-3-540-69297-3
isbn_softcover978-3-642-08881-0
isbn_ebook978-3-540-69297-3Series ISSN 0080-0015 Series E-ISSN 2197-6767
issn_series 0080-0015
copyrightSpringer-Verlag Berlin Heidelberg 2009
The information of publication is updating

书目名称Cancer Prevention II影响因子(影响力)




书目名称Cancer Prevention II影响因子(影响力)学科排名




书目名称Cancer Prevention II网络公开度




书目名称Cancer Prevention II网络公开度学科排名




书目名称Cancer Prevention II被引频次




书目名称Cancer Prevention II被引频次学科排名




书目名称Cancer Prevention II年度引用




书目名称Cancer Prevention II年度引用学科排名




书目名称Cancer Prevention II读者反馈




书目名称Cancer Prevention II读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:46:41 | 显示全部楼层
发表于 2025-3-22 01:22:47 | 显示全部楼层
Cancer Prevenpinon in the Developing World: Mission Impossible?lso thought to be a hallmark of the developed world, while on the contrary cancer is set to become the newest epidemic in the developing world..Based on the most recently estimated incidence rates, the 11 million cancer cases diagnosed in 2002 will reach roughly 17 million in 2020 and 27 million by
发表于 2025-3-22 06:14:13 | 显示全部楼层
Is Cancer Prevention Ever Going to Be Profitable?gets. Hence, the question arises of how many resources should be devoted to the management of cancers, given that resources are scarce and many other fields and specialities are competing for these resources. This paper addresses the question of whether preventive measures in oncology eventually pay
发表于 2025-3-22 09:34:26 | 显示全部楼层
The EPIC Study: An Update obtaining ethical approval from the International Agency for Research on Cancer (IARC) Ethical Review Committee and from the local ethical committees at the participating centres, participants were invited to take part in the study. After signing an informed consent agreement EPIC participants were
发表于 2025-3-22 16:17:00 | 显示全部楼层
Cancer Prevention by Vaccination Against Hepatitis Bccination program in Taiwan, chronic HBV infection (HBsAg seropositive) rates in the general population below 20 years of age have revealed a remarkable reduction from 10%–17% before the vaccination program to 0.7%–1.7% after the program. HCC incidence rate in children 6–14 years old also fell from
发表于 2025-3-22 20:27:19 | 显示全部楼层
The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancerrst degree female relatives (mother, sister, daughter) with a history of breast cancer and 9.2% of the women had a personal history of LCIS. A history of atypical hyperplasia of the breast was noted in 22.7% of the participants. The mean predicted 5-year risk of developing breast cancer among the st
发表于 2025-3-22 23:18:27 | 显示全部楼层
发表于 2025-3-23 05:03:23 | 显示全部楼层
发表于 2025-3-23 08:34:04 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 21:42
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表